Package Leaflet: Information for the User
Elvanse 70mg hard capsules
lisdexamfetamine dimesylate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack:
What is Elvanse
Elvanse contains the active substance lisdexamfetamine dimesylate, which acts on brain activity. It helps to improve attention, concentration, and reduce impulsivity.
Elvanse is a long-acting medicine that works gradually over 13 hours.
What is Elvanse used for
Elvanse is part of a comprehensive treatment program for “Attention Deficit Hyperactivity Disorder” (ADHD)
You should inform your doctor if you do not feel better or if you feel worse after one month of treatment. Elvanse is not recommended for all patients with ADHD, and the decision to use this medicine is based on a thorough medical evaluation.
Elvanse is not indicated for the treatment of ADHD in children under 6 years of age, as it is not known if it is safe or beneficial for such young individuals.
How Elvanse works
Elvanse improves the activity of certain parts of the brain that are underactive. The medicine may help improve attention, concentration, and reduce impulsive behavior.
The medicine is administered as part of a treatment program that usually includes:
It can only be prescribed by doctors who have experience in treating people with behavioral problems.
About ADHD
People with ADHD have difficulties:
These individuals are not to blame for being unable to do these things. However, ADHD can cause problems in daily life. Children and adolescents with ADHD may have difficulties learning and doing homework. They may have trouble behaving well at home, at school, and in other places.
ADHD does not affect a person's intelligence.
Do not take Elvanse:
Do not take Elvanse if you have any of the above conditions. If you are unsure, consult your doctor or pharmacist before taking Elvanse, as it may worsen these problems.
Warnings and precautions
Consult your doctor or pharmacist before starting treatment with Elvanse if:
Or if you are a woman who may become pregnant, plan to become pregnant, or are breastfeeding (see the section "Pregnancy and breastfeeding")
Tell your doctor or pharmacist if you have any of the above conditions before starting treatment. Elvanse may worsen these problems. Your doctor will want to monitor how the medicine affects you.
If not used correctly, Elvanse can cause abnormal behavior and dependence on the medicine. Inform your doctor if you or your child have ever abused or been dependent on alcohol, prescription medicines, or drugs. Do not give this medicine to anyone, even if they seem to have similar symptoms.
Elvanse may cause heart rhythm disorders in some patients. If you experience palpitations or irregular heartbeats during treatment, you should inform your doctor immediately. The risk of heart problems may increase with increasing dose. Therefore, you should follow the recommended dose.
Checks that your doctor will make before you start taking Elvanse
These checks are done to decide if Elvanse is the right medicine for you. Your doctor will ask you about:
It is essential that you provide as much information as possible. This will help your doctor decide if Elvanse is the right medicine for you. Your doctor may decide that other tests need to be done before you start taking this medicine.
Effect on weight
Using Elvanse with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Do not take Elvanse:
Elvanse may interact with other medicines. If you take any of the following medicines, consult your doctor or pharmacist before taking Elvanse:
If you are unsure if the medicines you are taking are on the list above, consult your doctor or pharmacist before taking Elvanse.
Doping control and use in athletes
Patients should be warned that this medicine may produce a positive result in doping tests.
Pregnancy and breastfeeding
If you are pregnant, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine.
Elvanse is transformed in the body into other substances that can cross the placenta and pass into breast milk.
Available data on the use of Elvanse during the first three months of pregnancy do not indicate an increased risk of congenital malformations in the child, but may increase the risk of preeclampsia (a condition that usually occurs after 20 weeks of pregnancy and is characterized by high blood pressure and proteins in the urine) and premature birth. Newborns exposed to amphetamine during pregnancy may exhibit withdrawal symptoms (tremor, irritability, muscle hypertonia). You should not use this medicine during pregnancy unless your doctor explicitly tells you to, nor breastfeed if you are taking Elvanse.
Driving and using machines
You may feel dizzy, have problems fixing your gaze, or see blurry when taking Elvanse. If this happens, it is dangerous to perform activities such as driving, using machines, riding a bicycle or horse, or climbing trees.
Elvanse contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per capsule; this is, essentially “sodium-free”.
How much to take
Follow your doctor's instructions for taking this medicine exactly. If you are unsure, consult your doctor or pharmacist again.
This medicine is only for you. Do not give this medicine to anyone else, even if they have similar symptoms.
The maximum daily dose is 70 mg.
How to take Elvanse
or Swallow the capsule whole with a glass of water.
or Open the capsule and empty the contents into:
Use a spoon to dissolve any lumps and mix Elvanse and yogurt, water, or orange juice well. Take all the yogurt or drink all the water or orange juice immediately after mixing with Elvanse. Do not store it. Do not worry if a film remains in the glass or container; it is not the active ingredient.
Dose
If you do not feel better after 1 month of treatment
If you do not feel better, inform your doctor. You may need a different treatment.
If you misuse Elvanse
If you take more Elvanse than you should
In case of overdose or accidental ingestion, consult a doctor, pharmacist, or call the Toxicology Information Service, phone 915620420, indicating the medicine and the amount taken.
Signs of overdose may include: restlessness, tremors, increased uncontrolled movements, muscle tremors, rapid breathing, confusion, tendency to fight or argue, seeing, hearing, or feeling things that are not real (hallucinations), panic state, high fever, or muscle collapse. You may then feel tired and depressed. You may also experience nausea, vomiting, diarrhea, and stomach cramps. There may also be changes in heart rate (slow, fast, or irregular), high or low blood pressure, circulatory collapse, seizures, and coma.
If you forget to take Elvanse
Do not take a double dose to make up for forgotten doses. If you forget a dose, wait until the next day. Avoid taking the dose in the afternoon due to the possibility of sleep disorders (insomnia).
If you stop taking Elvanse
If you stop taking this medicine, your ADHD symptoms may return.
Do not stop taking the medicine without first consulting your doctor. Do not stop taking the medicine suddenly or on your own.
What your doctor will do while you are taking Elvanse
Your doctor will perform some tests
Also, tests will be performed when you change dose. These tests will include:
-appetite control,
-height and weight measurement,
-blood pressure and pulse measurement,
-checking if you have had mood, mood, or any other unusual feelings or if these issues have worsened while taking Elvanse.
Long-term treatment
Elvanse does not need to be taken forever. If you take Elvanse for more than a year, your doctor should interrupt treatment for a short period, such as during vacations. This allows you to see if you still need the medicine.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. Your doctor will inform you about these adverse effects.
Some adverse effects can be serious. If any of the following adverse effects appear, go to the doctor immediately:
Frequent (may affect up to 1 in 10 people)
Infrequent (may affect up to 1 in 100 people)
Frequency not known (cannot be estimated from available data)
*The following serious adverse effects have a different frequency in children and adolescents compared to adults.
If you experience any of the above adverse effects, go to the doctor immediately.
Other adverse effects include the following. If they become severe, inform your doctor or pharmacist:
Very frequent (may affect more than 1 in 10 people)
Frequent (may affect up to 1 in 10 people)
Infrequent (may affect up to 1 in 100 people)
Frequency not known (cannot be estimated from available data)
*The following adverse effects have a different frequency in children and adolescents compared to adults.
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Do not store above 25°C.
Keep this medicine out of sight and reach of children.
Store this medicine in a safe and inaccessible place for other people. It can seriously harm people for whom it has not been prescribed.
Do not use this medicine after the expiration date that appears on the bottle and box after CAD. The expiration date is the last day of the month indicated.
Do not use this medicine if the capsules show any damage.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE collection point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Elvanse
The active ingredient is lisdexamfetamine dimesylate.
Each hard capsule of 70 mg contains 70 mg of lisdexamfetamine dimesylate, equivalent to 20.8 mg of dexamfetamine.
The other ingredients are:
Appearance and Package Contents
Hard capsules.
The 70 mg capsules have a blue opaque body and a pink opaque cap, with the printing "S489" and "70 mg" in black ink.
Package size: 28 or 30 capsules. Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Takeda Pharmaceuticals International AG Ireland Branch
Block 2 Miesian Plaza
50-58 Baggot Street Lower
Dublin 2, D02 HW68, Ireland
Email: medinfoEMEA@takeda.com
Manufacturer:
Shire Pharmaceuticals Ireland Limited
Block 2 & 3 Miesian Plaza
50-58 Baggot Street Lower
Dublin 2
Ireland
or
Takeda Pharmaceuticals International AG Ireland Branch
Block 2 Miesian Plaza
50 – 58 Baggot Street Lower
Dublin 2, D02 HW68
Ireland
or
Takeda GmbH,
Plant Oranienburg, Lehnitzstrasse 70-98,
16515 Oranienburg
Germany
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Takeda Farmacéutica España S.A.
Calle Albacete, 5, 9th floor,
Edificio Los Cubos
28027 Madrid
Spain
Tel: +34 91 790 42 22
This medicine is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:
Germany Elvanse
Austria Elvanse
Belgium Elvanse
Denmark Elvanse
Estonia Elvanse
Spain Elvanse
Finland Elvanse
Netherlands Elvanse
Ireland Tyvense
Luxembourg Elvanse
Norway Elvanse
Portugal Elvanse
Sweden Elvanse
United Kingdom (Northern Ireland) Elvanse
Date of the last revision of this leaflet: 11/2024.
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es